Merck KGaA
MRK
Xếp hạng trong cổ phiếu
#342
Merck KGaA is a German science and technology company with operations divided... Merck KGaA is a German science and technology company with operations divided into three core segments: Life Science, Healthcare, and Electronics. The Life Science division supplies essential tools, chemicals, and equipment to academic research institutions, biotechnology firms, pharmaceutical manufacturers, and various industrial sectors. It also offers specialized process development expertise, such as continuous bioprocessing for drug manufacturers, provides a range of testing kits, reagents, and services, and develops solutions for analyzing environmental samples like air, water, and soil. Furthermore, this segment aids in assessing nutritional value and identifying quality control issues. In its Healthcare segment, the company is involved in the entire lifecycle of prescription drugs and biopharmaceuticals, from initial discovery and development through manufacturing and marketing. Its therapeutic focus areas include oncology, neurology and immunology, fertility, endocrinology, cardiovascular diseases, diabetes, thyroid disorders, and multiple sclerosis. This segment also produces general medicines, injection devices, and software for disease monitoring. The Electronics division delivers critical materials for the semiconductor and display industries. It also specializes in surface design, providing delivery systems and services, along with a variety of surface solutions for applications such as cosmetics, effect pigments, and other functional materials. Merck KGaA is also actively engaged in strategic partnerships. These include in-licensing agreements with Debiopharm International SA for developing treatments for head and neck cancer, with Jiangsu Hengrui Pharmaceuticals Co. Ltd. for metastatic colorectal cancer drug candidates, and with Abbisko Therapeutics Co. Ltd. for therapies targeting tenosynovial giant cell tumors. Additionally, the company is involved in collaborations focused on discovering and developing targeted protein degraders against critical oncogenic proteins. Founded in 1668 and headquartered in Darmstadt, Germany, Merck KGaA operates as a subsidiary of E. Merck KG.
Giá cổ phiếu
$161.15
Đồng bộ lần cuối: 2026-10-21
Vốn hóa thị trường
$70.07B
Thay đổi (1 ngày)
-7.20%
Thay đổi (1 năm)
20.52%
Quốc gia
DE
Giao dịch Merck KGaA (MRK)
Danh mục
Healthcare
Lịch sử giá cổ phiếu của Merck KGaA (MRK)
Giá đóng cửa cao nhất: $165.46 vào 2026-10-01
Giá đóng cửa thấp nhất: $24.53 vào 1998-06-01
Giá đóng cửa thấp nhất: $24.53 vào 1998-06-01
Lịch sử giá cổ phiếu của Merck KGaA từ 1998 đến 2026
Hiệu suất giá cổ phiếu hàng năm
| Năm | Hiệu suất |
|---|---|
| 2026 (TTM) | 6.60% |
| 2025 | -5.42% |
| 2024 | -6.13% |
| 2023 | -17.42% |
| 2022 | -24.47% |
| 2021 | 51.93% |
| 2020 | 43.69% |
| 2019 | 6.62% |
| 2018 | 1.64% |
| 2017 | 4.92% |
| 2016 | 3.86% |
| 2015 | 0.91% |
| 2014 | 11.44% |
| 2013 | 29.39% |
| 2012 | 37.65% |
| 2011 | 21.74% |
| 2010 | -14.88% |
| 2009 | 13.22% |
| 2008 | -35.42% |
| 2007 | 22.01% |
| 2006 | 28.92% |
| 2005 | 29.71% |
| 2004 | 57.50% |
| 2003 | 57.68% |
| 2002 | -27.09% |
| 2001 | -12.13% |
| 2000 | 32.94% |
| 1999 | -30.16% |
| 1998 | 0.00% |
Giá cổ phiếu của các công ty hoặc đối thủ tương tự
| Công ty | Giá cổ phiếu | Thay đổi 1năm% | Quốc gia |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $40.44 | 43.06% |
JP
|
|
| $212.49 | 24.09% |
CH
|
|
| $19.19 | -0.09% |
IN
|
|
| $7.02 | -23.29% |
CN
|
